Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Screening for Silent Atrial Fibrillation During Influenza Vaccination

This study has been completed.
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
Monika Hollander, MD, PhD, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT02006524
First received: December 4, 2013
Last updated: May 11, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)